Oligonucleotide API CDMO – Service Overview

Comprehensive support from oligonucleotide therapeutics research to API production with our reliable technology

Service Description

Hokkaido System Science Co., Ltd. (HSS) comprehensively supports the research and development of oligonucleotide therapeutics, covering sequence design, synthesis, cell-based assays, animal experimentation, and gene analysis.

In addition, through a joint collaboration with Mitsubishi Gas Chemical Company, Inc. (MGC), we have established a GMP-compliant oligonucleotide manufacturing platform, enabling seamless, end-to-end support from early-stage research through to oligonucleotide API manufacturing.

CDMOサービスの流れ

Related Articles

Press Release: Business Collaboration Agreement for exploring Entry into Nucleic Acid Drug CDMO Business (July 12, 2024)

Features of HSS Custom Services

1
Flexible ordering is available from spot requests to total contracts for sequence design, synthesis, cell-based assays, animal experimentation, and gene analysis (evaluation systems).
2
Discount plans can be offered when ordering a combination of several services or an annual contract.
3
We can advise on research funding / grant proposal as a collaboration business.
A customized service plan will be proposed based on your consultation details, including schedule, budget, necessary processes, and issues.

Contact & Consultation

If you have any questions or would like to request a quote,
please feel free to contact us using the form below.

    Services of Interest (Optional / Multiple selection allowed)

    Purpose of Inquiry (Optional / Multiple selection allowed)

    ※ Free online consultations are available. Please indicate if required.

    Copyright © Hokkaido System Science Co.,Ltd. All rights reserved.

    Back to "Products & Services"
    Page Top